Biotek-snakken — Januar 2022
-
Kigger man eks på Genmab, så langede de kaftigt ud efter GSK´s BCMA ADC fordi der var store problemer med øje-tox. Nu har de det selv med Tivdak og så er det ikke længere verdens undergang. Så man skal aldrig helt stille sig til tåls med diverse bioteksselskabers egen fortolkninger, tror jeg.
-
-
This Biotech Stock Just Collapsed; Why One Analyst Still Has Hope
Sutro stock collapsed Thursday — and was among the biggest biotech stock dives — after its ovarian cancer study disappointed investors.
Investor's Business Daily (www.investors.com)
-
Har du prøvet hjemmesiden?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind